Join us at BIO-Europe 2024 in Stockholm, Sweden. If you would like to meet with us at Bio-Europe, please provide your contact details below. We will get back to you as soon as possible.
Evotec At BIO-Europe 2024
“Under Attack”: Can cell & gene therapy revolutionize the rules of healthcare?
Delve into the groundbreaking potential of cell and gene therapy and it’s potential to reshape healthcare as we know it. Explore the transformative impact of these therapies on disease treatment and prevention, challenging conventional medical paradigms. Discover how these innovative modalities are rewriting the rules of healthcare for a brighter future.
Date: Tuesday, 5 November
Time: 16:00 - 16:45 CET
Location: Room K2
Moderated by Romain Bonnot, Principal at ZS Associates
Speakers include:
- Bernd Muehlenweg, SVP Global Business Development at Evotec
- Celine Carlet, VP Head of Transactions at Galapagos
- Daniel Kemp, CEO Shinobi Therapeutics
- Michael May, President & CEO at CCRM
- Reagan Jarvis, CEO Scientific founder at Anocca
“I Have a Dream” AI for Drug Discovery
Hear how AI algorithms are reshaping the landscape, accelerating the identification and development of novel therapeutics. Learn from industry experts about the latest advancements, challenges, and promising opportunities in this frontier of innovation.
Date: Tuesday, 5 November
Time: 16:00 - 16:45 CET
Location: Room K1
Moderated by Dr. Maria Luisa Pineda, Vice Chair, Cofounder and Board Member at Envisagenics
Speakers include:
- Tim James, VP Head of in silico R&D at Evotec
- Hartmut Juhl, CEO at Indivumed GmbH
- Lovisa Afzelius, General Partner at Flagship Pioneering
- Michelle Chen, CBO at Insilico Medicine
- Nikolaus Krall, EVP Precision Medicine at Excienstia
- Rogier Rooswinkel, General Partner at Forbion
- Stephan Brock, CEO at Molecular Health
